Home
Astrazeneca Pharma India Ltd Quarterly Result

Astrazeneca Pharma India Ltd
NSE: ASTRAZEN
Net Profit - Last Quarter
Astrazeneca Pharma India Ltd Quarterly Results Key Highlights
- The revenue of Astrazeneca Pharma India Ltd for the Dec '24 is ₹ 448.27 crore as compare to the Sep '24 revenue of ₹ 416.15 crore.
- This represent the growth of 7.72%a1# The ebitda of Astrazeneca Pharma India Ltd for the Dec '24 is ₹ 51.42 crore as compare to the Sep '24 ebitda of ₹ 60.69 crore.
- This represent the decline of -15.27%a1# The net profit of Astrazeneca Pharma India Ltd for the Dec '24 is ₹ 30.85 crore as compare to the Sep '24 net profit of ₹ 38.43 crore.
- This represent the decline of -19.72%a1#.
Astrazeneca Pharma India Ltd Quarterly Results Analysis
Market Price of Astrazeneca Pharma India Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 6868.75 |
20 Feb 2025 | 6976.5 |
19 Feb 2025 | 6942.7 |
18 Feb 2025 | 6958 |
17 Feb 2025 | 7030.05 |
14 Feb 2025 | 7096.35 |
13 Feb 2025 | 7410.6 |
12 Feb 2025 | 7494.65 |
11 Feb 2025 | 7466.85 |
10 Feb 2025 | 7535.1 |
Historical Revenue of Astrazeneca Pharma India Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Astrazeneca Pharma India Ltd
Historical EBITDA of Astrazeneca Pharma India Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Astrazeneca Pharma India Ltd
Historical Net Profit of Astrazeneca Pharma India Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Astrazeneca Pharma India Ltd
Astrazeneca Pharma India Ltd News Hub
AstraZeneca slumps on recording dismal Q1 performance
Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter ended 30
Read more
08 Aug 24
Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter
Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as ag
Read more
08 Aug 24
Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions
Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed by IMFINZI
Read more
24 Sept 24
Astrazeneca Pharma India Ltd leads gainers in 'A' group
Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and National Alumini
Read more
24 Sept 24